AI misses 14% of invasive breast cancers on mammography, with luminal cancers and dense tissue posing significant challenges.
Key Details
- 1Study analyzed 1,097 breast cancers from 1,082 women using Lunit Insight MMG AI between 2014–2020.
- 2AI missed 154 cancers (14%), often in younger women with smaller (<2 cm), lower-grade tumors and dense breasts.
- 3Missed cancers were more likely luminal subtype (false-negative rate 17.2%), compared to HER2-enriched (9%) and triple-negative (14.5%).
- 4Major reasons for AI misses included dense breast tissue (n=56), nonmammary zone location (n=22), architectural distortion (n=12), and amorphous calcifications (n=5).
- 561.7% of AI-missed cancers were deemed 'actionable' on further review by radiologists.
Why It Matters
Understanding which cancer features are often overlooked by AI tools enables radiologists to better interpret AI results, reducing missed diagnoses. These insights highlight the continued importance of human expertise in mammography, especially for high-risk groups like women with dense breast tissue.
Source
AuntMinnie
Related News
•Health Imaging
AI as Second Reader Surpasses Radiologists in Breast Cancer Screening
AI used as a second reader on mammograms improves cancer detection rates compared to radiologists alone.
•Health Imaging
AI-Powered Ultrasound Tool Predicts Delivery Timing for Pregnant Patients
Researchers have created an AI model using ultrasound to accurately forecast expectant mothers’ delivery timelines.
•AuntMinnie
ChatGPT-4 Turbo Powers Postdeployment Monitoring of ICH Detection AI
Researchers found ChatGPT-4 Turbo could efficiently monitor the performance of Aidoc's ICH detection AI across real-world radiology practices.